Blog
RSS FeedPosted by Michael Wonder on 07 Feb 2018
PHARMAC widening access to Truvada for the prevention of HIV infection
7 February 2018 - Decision means Truvada will be funded for pre-exposure prophylaxis in New Zealand before Australia. ...
Posted by Michael Wonder on 06 Feb 2018
NICE restricts NHS use of Roche’s IPF drug Esbriet
6 February 2018 - Cost regulators for NHS therapies in England and Wales have now issued final guidelines endorsing the ...
Posted by Michael Wonder on 06 Feb 2018
Quebec adds Erelzi (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
5 February 2018 - Erelzi has been added to the Quebec Drug Insurance Plan based on specific criteria for the treatment ...
Posted by Michael Wonder on 05 Feb 2018
Acerus Pharma’s Natesto to be listed for public reimbursement in Quebec
1 February 2018 - Acerus Pharmaceuticals Corporation today announced that it has received notice from Quebec’s National Institute for Excellence ...
Posted by Michael Wonder on 05 Feb 2018
Announcing the passing of Professor Alan Maynard
5 February 2018 - The University of York is deeply saddened to announce that Alan Maynard, Emeritus Professor of Health Economics ...
Posted by Michael Wonder on 05 Feb 2018
Thank Mediscare for high private health insurance premiums
6 February 2018 - In last year's Budget, the government declared open season on the banks. Why? Because they made ...
Posted by Michael Wonder on 05 Feb 2018
New independent chair wants improved equitable access to breakthrough medicines
1 February 2018 - Former clinical leader, Dr. Lee Mathias, has been appointed as new chair for Medicines New Zealand ...
Posted by Michael Wonder on 04 Feb 2018
The real story behind the sudden drop in Canada's drug prices
3 February 2018 - And is Ontario offering a college diploma in 'pseudoscience?' ...
Posted by Michael Wonder on 03 Feb 2018
Free meningococcal vaccine backed at national level
3 January 2018 - Two weeks ago there was no funding for a vaccine that protects against four strains of ...
Posted by Michael Wonder on 01 Feb 2018
NHS England takes charge on market access
1 February 2018 - Today sees patients gain full NHS access to breast cancer drug Perjeta, a full six years ...
Posted by Michael Wonder on 01 Feb 2018
Final NHS nod for Janssen’s Imbruvica
1 February 2018 - Janssen’s Imbruvica will be routinely available on the NHS to treat certain patients with mantle cell ...
Posted by Michael Wonder on 01 Feb 2018
Advance notice of consultation about changes to the Pharmaceutical Schedule Rules
1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply. ...
Posted by Michael Wonder on 01 Feb 2018
NICE, the NHS, and cancer drugs
31 January 2018 - Drug costs are an issue in virtually every country and particularly in the United States. In ...
Posted by Michael Wonder on 31 Jan 2018
Schedule of Pharmaceutical Benefits - 1 February 2018 update
1 February 2018 - The February 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jan 2018
New Zealand Pharmaceutical Schedule - 1 February 2018
1 February 2018 - The February 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...